The Centers for Medicare and Medicaid Services and NCI said they are developing a Memorandum of Understanding to address how the agencies can work together to improve the process for making coverage decisions for cancer therapy and diagnosis.
Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.
Access to mammography needs improvement, IOM National Cancer Policy Board report finds.
NCAB, President’s Cancer Panel honor the late Paul Calabresi.
Funding opportunities listed.
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
